Skip to main content

Table 8 Cox regression analysis of breast cancer patients with TNM III ~ IV stages. 107 breast cancer patients with TNM III ~ IV stages were included and the Cox regression analysis was used to study the effects of C1orf63 expression on overall survival (OS). HR, hazard ratio; 95 % CI: 95 % Confidence Interval

From: Elevated C1orf63 expression is correlated with CDK10 and predicts better outcome for advanced breast cancers: a retrospective study

Variables

Univariate analysis

Multivariate analysis

HR (95 % CI)*

P

HR (95 % CI)*

P

Age, year

1.50 (0.76, 2.95)

0.239

  

Depth of invasion

1.37 (0.74, 2.52)

0.32

  

Lymph node metastasis

1.26 (0.59, 2.72)

0.549

  

ER

0.69 (0.39, 1.24)

0.218

  

PR

0.52 (0.27, 0.97)

0.039

0.51 (0.27, 0.95)

0.035

HER2

1.62 (0.91, 2.90)

0.102

  

C1orf63

0.41 (0.18, 0.98)

0.044

0.41 (0.17, 0.97)

0.042

  1. *HR, hazard ratio; 95 % CI: 95 % Confidence Interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us